Cargando…

Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis

Current evidence supports a maximized extent of resection (EOR) in low-grade gliomas (LGG), regardless of different histological subtypes and molecular markers. We therefore evaluated the prognostic impact of extensive, mainly intraoperative (i)MRI-guided surgery in low-grade astrocytomas stratified...

Descripción completa

Detalles Bibliográficos
Autores principales: Jungk, Christine, Scherer, Moritz, Mock, Andreas, Capper, David, Radbruch, Alexander, von Deimling, Andreas, Bendszus, Martin, Herold-Mende, Christel, Unterberg, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992014/
https://www.ncbi.nlm.nih.gov/pubmed/27344556
http://dx.doi.org/10.1007/s11060-016-2177-y
_version_ 1782448935383597056
author Jungk, Christine
Scherer, Moritz
Mock, Andreas
Capper, David
Radbruch, Alexander
von Deimling, Andreas
Bendszus, Martin
Herold-Mende, Christel
Unterberg, Andreas
author_facet Jungk, Christine
Scherer, Moritz
Mock, Andreas
Capper, David
Radbruch, Alexander
von Deimling, Andreas
Bendszus, Martin
Herold-Mende, Christel
Unterberg, Andreas
author_sort Jungk, Christine
collection PubMed
description Current evidence supports a maximized extent of resection (EOR) in low-grade gliomas (LGG), regardless of different histological subtypes and molecular markers. We therefore evaluated the prognostic impact of extensive, mainly intraoperative (i)MRI-guided surgery in low-grade astrocytomas stratified for IDH1 mutation status. Retrospective assessment of 46 consecutive cases of newly diagnosed supratentorial WHO grade II astrocytomas treated during the last decade was performed. IDH1 mutation status was obtained for all patients. Volumetric analysis of tumor volumes was performed pre-, intra-, early postoperatively and at first follow-up. Survival analysis was conducted with uni-and multivariate regression models implementing clinical parameters and continuous volumetric variables. Median EOR was 90.4 % (range 17.5–100 %) and was increased to 94.9 % (range 34.8–100 %) in iMRI-guided resections (n = 33). A greater EOR was prognostic for increased progression-free survival (HR 0.23, p = 0.031) and time to re-intervention (TTR) (HR 0.23, p = 0.03). In IDH1 mutant patients, smaller residual tumor volumes were associated with increased TTR (HR 1.01, p = 0.03). IDH1 mutation (38/46 cases) was an independent positive prognosticator for overall survival (OS) in multivariate analysis (HR 0.09, p = 0.002), while extensive surgery had limited impact upon OS. In a subgroup of patients with ≥40 % EOR (n = 39), however, initial and residual tumor volumes were prognostic for OS (HR 1.03, p = 0.005 and HR 1.08, p = 0.007, respectively), persistent to adjustment for IDH1. No association between EOR and neurologic morbidity was found. In this analysis of low-grade astrocytomas stratified for IDH1, extensive tumor resections were prognostic for progression and TTR and, in patients with ≥40 % EOR, for OS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-016-2177-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4992014
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-49920142016-09-06 Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis Jungk, Christine Scherer, Moritz Mock, Andreas Capper, David Radbruch, Alexander von Deimling, Andreas Bendszus, Martin Herold-Mende, Christel Unterberg, Andreas J Neurooncol Clinical Study Current evidence supports a maximized extent of resection (EOR) in low-grade gliomas (LGG), regardless of different histological subtypes and molecular markers. We therefore evaluated the prognostic impact of extensive, mainly intraoperative (i)MRI-guided surgery in low-grade astrocytomas stratified for IDH1 mutation status. Retrospective assessment of 46 consecutive cases of newly diagnosed supratentorial WHO grade II astrocytomas treated during the last decade was performed. IDH1 mutation status was obtained for all patients. Volumetric analysis of tumor volumes was performed pre-, intra-, early postoperatively and at first follow-up. Survival analysis was conducted with uni-and multivariate regression models implementing clinical parameters and continuous volumetric variables. Median EOR was 90.4 % (range 17.5–100 %) and was increased to 94.9 % (range 34.8–100 %) in iMRI-guided resections (n = 33). A greater EOR was prognostic for increased progression-free survival (HR 0.23, p = 0.031) and time to re-intervention (TTR) (HR 0.23, p = 0.03). In IDH1 mutant patients, smaller residual tumor volumes were associated with increased TTR (HR 1.01, p = 0.03). IDH1 mutation (38/46 cases) was an independent positive prognosticator for overall survival (OS) in multivariate analysis (HR 0.09, p = 0.002), while extensive surgery had limited impact upon OS. In a subgroup of patients with ≥40 % EOR (n = 39), however, initial and residual tumor volumes were prognostic for OS (HR 1.03, p = 0.005 and HR 1.08, p = 0.007, respectively), persistent to adjustment for IDH1. No association between EOR and neurologic morbidity was found. In this analysis of low-grade astrocytomas stratified for IDH1, extensive tumor resections were prognostic for progression and TTR and, in patients with ≥40 % EOR, for OS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-016-2177-y) contains supplementary material, which is available to authorized users. Springer US 2016-06-25 2016 /pmc/articles/PMC4992014/ /pubmed/27344556 http://dx.doi.org/10.1007/s11060-016-2177-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Study
Jungk, Christine
Scherer, Moritz
Mock, Andreas
Capper, David
Radbruch, Alexander
von Deimling, Andreas
Bendszus, Martin
Herold-Mende, Christel
Unterberg, Andreas
Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis
title Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis
title_full Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis
title_fullStr Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis
title_full_unstemmed Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis
title_short Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis
title_sort prognostic value of the extent of resection in supratentorial who grade ii astrocytomas stratified for idh1 mutation status: a single-center volumetric analysis
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992014/
https://www.ncbi.nlm.nih.gov/pubmed/27344556
http://dx.doi.org/10.1007/s11060-016-2177-y
work_keys_str_mv AT jungkchristine prognosticvalueoftheextentofresectioninsupratentorialwhogradeiiastrocytomasstratifiedforidh1mutationstatusasinglecentervolumetricanalysis
AT scherermoritz prognosticvalueoftheextentofresectioninsupratentorialwhogradeiiastrocytomasstratifiedforidh1mutationstatusasinglecentervolumetricanalysis
AT mockandreas prognosticvalueoftheextentofresectioninsupratentorialwhogradeiiastrocytomasstratifiedforidh1mutationstatusasinglecentervolumetricanalysis
AT capperdavid prognosticvalueoftheextentofresectioninsupratentorialwhogradeiiastrocytomasstratifiedforidh1mutationstatusasinglecentervolumetricanalysis
AT radbruchalexander prognosticvalueoftheextentofresectioninsupratentorialwhogradeiiastrocytomasstratifiedforidh1mutationstatusasinglecentervolumetricanalysis
AT vondeimlingandreas prognosticvalueoftheextentofresectioninsupratentorialwhogradeiiastrocytomasstratifiedforidh1mutationstatusasinglecentervolumetricanalysis
AT bendszusmartin prognosticvalueoftheextentofresectioninsupratentorialwhogradeiiastrocytomasstratifiedforidh1mutationstatusasinglecentervolumetricanalysis
AT heroldmendechristel prognosticvalueoftheextentofresectioninsupratentorialwhogradeiiastrocytomasstratifiedforidh1mutationstatusasinglecentervolumetricanalysis
AT unterbergandreas prognosticvalueoftheextentofresectioninsupratentorialwhogradeiiastrocytomasstratifiedforidh1mutationstatusasinglecentervolumetricanalysis